|
1
|
Gennari L, Rotatori S, Bianciardi S,
Gonnelli S, Nuti R and Merlotti D: Appropriate models for novel
osteoporosis drug discovery and future perspectives. Expert Opin
Drug Discov. 10:1201–1216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sambrook P and Cooper C: Osteoporosis.
Lancet. 17:2010–2018. 2006.
|
|
3
|
Arceo-Mendoza RM and Camacho P: Prediction
of fracture risk in patients with osteoporosis: A brief review.
Womens Health (Lond Engl). 11:477–482. 2015. View Article : Google Scholar
|
|
4
|
Iñiguez-Ariza NM and Clarke BL: Bone
biology, signaling pathways, and therapeutic targets for
osteoporosis. Maturitas. 82:245–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mikami Y, Matsumoto T, Kano K, Toriumi T,
Somei M, Honda MJ and Komiyama K: Current status of drug therapies
for osteoporosis and the search for stem cells adapted for bone
regenerative medicine. Anat Sci Int. 89:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vitale AM, Wolvetang E and Mackay-Sim A:
Induced pluripotent stem cells: A new technology to study human
diseases. Int J Biochem Cell Biol. 43:843–846. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tögel F and Westenfelder C: Adult bone
marrow-derived stem cells for organ regeneration and repair. Dev
Dyn. 236:3321–3331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hentze H, Graichen R and Colman A: Cell
therapy and the safety of embryonic stem cell-derived grafts.
Trends Biotechnol. 25:24–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chamberlain G, Fox J, Ashton B and
Middleton J: Concise review: Mesenchymal stem cells: Their
phenotype, differentiation capacity, immunological features, and
potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ozawa K, Sato K, Oh I, Ozaki K, Uchibori
R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, et al: Cell and
gene therapy using mesenchymal stem cells (MSCs). J Autoimmun.
30:121–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jethva R, Otsuru S, Dominici M and Horwitz
EM: Cell therapy for disorders of bone. Cytotherapy. 11:3–17. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van Damme A, Driessche T Vanden, Collen D
and Chuah MK: Bone marrow stromal cells as targets for gene
therapy. Curr Gene Ther. 2:195–209. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan FF, Liu Y, Liu YF and Zhao YX: Herba
epimedii water extract elevates estrogen level and improves lipid
metabolism in postmenopausal women. Phytother Res. 22:1224–1228.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sze SC, Tong Y, Ng TB, Cheng CL and Cheung
HP: Herba epimedii: Anti-oxidative properties and its medical
implications. Molecules. 15:7861–7870. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen WF, Mok SK, Wang XL, Lai KH, Lai WP,
Luk HK, Leung PC, Yao XS and Wong MS: Total flavonoid action of the
Herba epimedii extract suppresses urinary calcium excretion and
improves bone properties in ovariectomised mice. Br J Nutr.
105:180–189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nadri S and Soleimani M: Isolation murine
mesenchymal stem cells by positive selection. In Vitro Cell Dev
Biol Anim. 43:276–282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eslaminejad MB and Nadri S: Murine
mesenchymal stem cell isolated and expanded in low and high density
culture system: Surface antigen expression and osteogenic culture
mineralization. In Vitro Cell Dev Biol Anim. 45:451–459. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bonab MM, Alimoghaddam K, Talebian F,
Ghaffari SH, Ghavamzadeh A and Nikbin B: Aging of mesenchymal stem
cells in vitro. BMC Cell Biol. 7:142006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yee AS, Paulson EK, McDevitt MA,
Rieger-Christ K, Summerhayes I, Berasi SP, Kim J, Huang CY and
Zhang X: The HBP1 transcriptional repressor and the p38 MAP kinase:
Unlikely partners in G1 regulation and tumor suppression. Gene.
336:1–13. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oliver L, Hue E, Rossignol J, Bougras G,
Hulin P, Naveilhan P, Heymann D, Lescaudron L and Vallette FM:
Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone
marrow mesenchymal stem cells during differentiation. PLoS One.
6:e198202011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Napolitano MA, Cipollaro M, Cascino A,
Melone MA, Giordano A and Galderisi U: Brg1 chromatin remodeling
factor is involved in cell growth arrest, apoptosis and senescence
of rat mesenchymal stem cells. J Cell Sci. 15:2904–2911. 2007.
|
